Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...

Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday as strong demand for its cough-and-cold ...

The stock's rise snapped a three-day losing streak.

(NYSE: KVUE) today announced financial results for the first quarter ended March 30, 2025. "In Q1, our teams executed our ...

The leadership change comes at the end of a week in which the California-based toymaker landed squarely in the crosshairs of ...

Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.

The Neutrogena and Aveeno owner has also increased its 2025 full-year outlook to reflect the impact of costs associated with ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSofya Tsinis - Head of Investor RelationsThibaut ...

The stock's fall snapped a six-day winning streak.

Kenvue KVUE1.58%increase; green up pointing triangle, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial ...

Net ...

May 8 (Reuters) - Kenvue (KVUE.N), opens new tab on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a $150 million impact from ...